Digiomics
Ylivieska
About Digiomics
It is a microfluidics company that has developed a method of targeting and lysing single cells in a complex background of other cells for –omics based analysis of the single cells. This technology is used for isolating fetal cells from PAP-smear samples to develop a minimal invasive prenatal genetic diagnostic test.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2016)
- Website: digiomics.com
Industries & Categories
Biotechnology, Medical
Canonical: https://fsome.com/organization/digiomics-1613440 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.